Home > Income Statement > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹411 Cr₹454 Cr₹362 Cr₹317 Cr₹109 Cr

What is the latest Consolidated Net Profit of SUVEN PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of SUVEN PHARMACEUTICALS is ₹411 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹411 Cr
Mar2023₹454 Cr
Mar2022₹362 Cr
Mar2021₹317 Cr
Mar2020₹109 Cr

How is Consolidated Net Profit of SUVEN PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹411 Cr
-9.37
Mar2023 ₹454 Cr
25.24
Mar2022 ₹362 Cr
14.30
Mar2021 ₹317 Cr
190.10
Mar2020 ₹109 Cr -

Compare Consolidated Net Profit of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹40,647.4 Cr 6.7% 7% 24.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,091.0 Cr 2.3% 3.2% 9.5% Stock Analytics
DIVIS LABORATORIES ₹181,302.0 Cr -0.2% 4.5% 49.6% Stock Analytics
CIPLA ₹119,038.0 Cr -0.2% -2% -1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹117,170.0 Cr 3.7% 6.5% 16.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,061.0 Cr -0% -4.6% -6.2% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

6.7%

7%

24.4%

SENSEX

-1.1%

1%

3.4%


You may also like the below Video Courses